Passage Bio, Inc.
PASGHealthcare|Biotechnology|US
$3.98
+0.52 (+14.88%)
DCF Value
$6.70
Tangible Book / Share
$1.39
Cash / Share
$7.53
Clinical Trials (4)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT03047369 The Myelin Disorders Biorepository Project | Leukodystrophy, White Matter Disease | Recruiting | 12,000 | — | — | |
| NCT04747431 A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes | Frontotemporal Dementia, FTD | P1P2 | Terminated | 30 | Open-label | PBFT02 |
| NCT05368038 ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program | Acid Sphingomyelinase Deficiency, Ceroid Lipofuscinosis, Neuronal, 2 | By Invite | 100,000 | — | — | |
| NCT04041102 Natural History Study of Infantile and Juvenile GM1 Gangliosidosis (GM1) Patients | GM1 Gangliosidosis | Completed | 31 | — | — |